Hidroxicloroquine and cloroquine safety profile in patients with SARS-COV-2 infection (COVID-19) (SEHISACoV-2)

Documents

Study protocol

Study results

Study report

Other information

Publications

Study publications

Chatre, C., Roubille, F., Vernhet, H. et al. Cardiac Complications Attributed t…

Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic revie…

White NJ. Cardiotoxicity of antimalarial drugs. The Lancet infectious diseases…

Haeusler, I.L., Chan, X.H.S., Guérin, P.J. et al. The arrhythmogenic cardiotoxi…

Tönnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy–a review of the…